ID   LIXC127
AC   CVCL_B7AQ
SY   LIXC-127
DR   CCRID; 4201PAT-CCTCC00868
DR   Wikidata; Q112930000
RX   Patent=CN107541494A;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201662.
CC   Population: Chinese; Han.
CC   Doubling time: 43.6 hours (Patent=CN107541494A).
CC   Derived from site: In situ; Bile duct; UBERON=UBERON_0002394.
DI   NCIt; C4436; Cholangiocarcinoma
DI   ORDO; Orphanet_70567; Cholangiocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
RX   Patent=CN107541494A;
RA   Zheng Y.-X., Guo X.-L., Yang B., Xie F.-B., Li L., Lin K., Wang Z.-Y.,
RA   Zhou H.;
RT   "A kind of human bile duct carcinoma system and its application.";
RL   Patent number CN107541494A, 05-Jan-2018.
//